UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. More Details
UDG passed our risk checks.
Flawless balance sheet with solid track record and pays a dividend.
Share Price & News
How has UDG Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: UDG is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: UDG's weekly volatility (3%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: UDG underperformed the UK Healthcare industry which returned 37.8% over the past year.
Return vs Market: UDG exceeded the UK Market which returned 23.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is UDG Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StIs Now The Time To Put UDG Healthcare (LON:UDG) On Your Watchlist?
3 weeks ago | Simply Wall StShane Cooke Is The Independent & Non-Executive Chairman of UDG Healthcare plc (LON:UDG) And They Just Picked Up 81% More Shares
1 month ago | Simply Wall StWhat Type Of Shareholders Make Up UDG Healthcare plc's (LON:UDG) Share Registry?
Is UDG Healthcare undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: UDG (£8.34) is trading below our estimate of fair value (£10.62)
Significantly Below Fair Value: UDG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: UDG's PE Ratio (30.9x) is in line with the GB Healthcare industry average.
PE vs Market: UDG is poor value based on its PE Ratio (30.9x) compared to the UK market (25.7x).
Price to Earnings Growth Ratio
PEG Ratio: UDG is poor value based on its PEG Ratio (3x)
Price to Book Ratio
PB vs Industry: UDG is overvalued based on its PB Ratio (2.9x) compared to the GB Healthcare industry average (1.8x).
How is UDG Healthcare forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: UDG's forecast earnings growth (10.3% per year) is above the savings rate (1%).
Earnings vs Market: UDG's earnings (10.3% per year) are forecast to grow slower than the UK market (21.5% per year).
High Growth Earnings: UDG's earnings are forecast to grow, but not significantly.
Revenue vs Market: UDG's revenue (5.9% per year) is forecast to grow slower than the UK market (6.7% per year).
High Growth Revenue: UDG's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: UDG's Return on Equity is forecast to be low in 3 years time (11.2%).
How has UDG Healthcare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: UDG has high quality earnings.
Growing Profit Margin: UDG's current net profit margins (7.3%) are higher than last year (4.4%).
Past Earnings Growth Analysis
Earnings Trend: UDG's earnings have grown by 4.2% per year over the past 5 years.
Accelerating Growth: UDG's earnings growth over the past year (61.1%) exceeds its 5-year average (4.2% per year).
Earnings vs Industry: UDG earnings growth over the past year (61.1%) exceeded the Healthcare industry 15.3%.
Return on Equity
High ROE: UDG's Return on Equity (9.4%) is considered low.
How is UDG Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: UDG's short term assets ($597.2M) exceed its short term liabilities ($311.2M).
Long Term Liabilities: UDG's short term assets ($597.2M) exceed its long term liabilities ($469.2M).
Debt to Equity History and Analysis
Debt Level: UDG's debt to equity ratio (28.2%) is considered satisfactory.
Reducing Debt: UDG's debt to equity ratio has reduced from 71.7% to 28.2% over the past 5 years.
Debt Coverage: UDG's debt is well covered by operating cash flow (83.3%).
Interest Coverage: UDG's interest payments on its debt are well covered by EBIT (11.4x coverage).
What is UDG Healthcare current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: UDG's dividend (1.49%) is higher than the bottom 25% of dividend payers in the UK market (1.39%).
High Dividend: UDG's dividend (1.49%) is low compared to the top 25% of dividend payers in the UK market (4.18%).
Stability and Growth of Payments
Stable Dividend: UDG's dividends per share have been stable in the past 10 years.
Growing Dividend: UDG's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (45.9%), UDG's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: UDG's dividends in 3 years are forecast to be well covered by earnings (33.1% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Brendan McAtamney (57 yo)
Mr. Brendan Patrick McAtamney has been the Group Chief Executive Officer of UDG Healthcare plc since February 2, 2016 and has been an Executive Director since December 16, 2013. Mr. McAtamney has been a No...
CEO Compensation Analysis
Compensation vs Market: Brendan's total compensation ($USD2.09M) is about average for companies of similar size in the UK market ($USD1.77M).
Compensation vs Earnings: Brendan's compensation has been consistent with company performance over the past year.
Experienced Management: UDG's management team is considered experienced (3.5 years average tenure).
Experienced Board: UDG's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: UDG insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
UDG Healthcare plc's company bio, employee growth, exchange listings and data sources
- Name: UDG Healthcare plc
- Ticker: UDG
- Exchange: LSE
- Founded: 1948
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: UK£2.099b
- Shares outstanding: 251.88m
- Website: https://www.udghealthcare.com
Number of Employees
- UDG Healthcare plc
- Citywest Business Campus
- 20 Riverwalk
- Co. Dublin
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and interna...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/12 18:57|
|End of Day Share Price||2021/04/12 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.